Core Viewpoint - The company, Yiduoli, is actively expanding its overseas market presence and enhancing its marketing network, with ongoing product registrations in over 30 countries and regions globally [1]. Group 1: Market Expansion - The company has increased its efforts in overseas market expansion [1]. - It has established subsidiaries in Germany and Australia, along with an office in Russia [1]. - A subsidiary in Brazil is in the process of being set up, expected to be completed in the first half of next year, which will enhance sales coverage in the Latin American region [1]. Group 2: Product Registration - The company is continuously adding new product registrations [1]. - It has successfully registered products in more than 30 countries and regions worldwide [1].

（编辑 姚尧） 证券日报网12月24日讯 ，溢多利在12月23日回答调研者提问时表示，公司将结合不同国家和地区的贸 易政策制定有针对性的应对方案，包括与贸易商合作或在当地成立本土品牌等方式。目前公司在美国市 场销售占比较小，相关政策不会对公司经营造成较大影响。 ...

Group 1: Company Overview and Financial Performance - The company, Guangdong Yiduoli Biotechnology Co., Ltd., has registered products in over 30 countries and regions globally, with subsidiaries in Germany, Australia, and a representative office in Russia, and is in the process of establishing a subsidiary in Brazil, expected to be completed in the first half of next year [1][2]. - The company's gross profit margin has consistently remained above 40%, while the net profit margin is only around 3%, primarily due to increased R&D and financial expenses [4]. - Capital expenditures have increased due to the upgrade of the R&D center and the establishment of new production bases, with significant projects currently under construction [4]. Group 2: Market Strategy and Challenges - The company is developing targeted strategies to mitigate potential negative impacts from U.S.-China trade tensions, including collaborating with traders and establishing local brands [2]. - The sales proportion in the U.S. market is currently small, indicating that related policies are unlikely to significantly affect the company's operations [2]. Group 3: Product Development and Sales - The company currently engages in NMN business as a raw material OEM for clients [3]. - The newly launched hydrogen peroxide enzyme product is used in the cleaning process of electronic products, with sales and gross margins improving compared to the previous year, although its overall revenue contribution remains small [5].

证券日报网讯12月17日，溢多利（300381）在互动平台回答投资者提问时表示，截至2025年12月10日， 公司股东人数为20324户。 ...

格隆汇12月17日丨溢多利(300381.SZ)在投资者互动平台表示，公司目前没有工业大麻业务。 （原标题：溢多利(300381.SZ)：公司目前没有工业大麻业务） ...

Core Viewpoint - Yidoli is actively enhancing its product offerings in the food enzyme sector through continuous research and development, aiming to improve strain performance and production processes while expanding its competitive edge in the food industry [2] Group 1: Product Offerings - The company’s food enzymes include high-temperature α-amylase, fungal α-amylase, pullulanase, xylanase, and glucose oxidase, which are widely used in industries such as starch sugar, alcohol, beverages, and baking [2] Group 2: Innovation and Market Demand - The company plans to strengthen application research and development in the food industry to launch new products that meet market demands, thereby further enhancing its product competitiveness [2]

证券日报网讯 12月3日，溢多利在互动平台回答投资者提问时表示，截至2025年11月28日，公司股东人 数为20286户。 （文章来源：证券日报） ...

Group 1 - The core point of the article is that Yiduoli announced the pledge and release of shares by its controlling shareholder, Zhuhai Jindadi Investment Co., Ltd. [2] - The pledged shares amount to 12.5 million shares, with the pledge starting on November 27, 2025, and the release date set for November 28, 2025 [2]

Group 1 - The core point of the article is that Yiduoli (SZ 300381) announced that as of the announcement date, Jindadi Investment has pledged a total of 37.5 million shares, accounting for 26.32% of its holdings [1] - For the year 2024, Yiduoli's revenue composition is as follows: 83.57% from the biomanufacturing industry, 15.71% from the bio-agriculture and animal husbandry industry, and 0.72% from other industries [1] - The current market capitalization of Yiduoli is 3.4 billion yuan [2]

Core Viewpoint - The announcement from Yiduoli indicates that the controlling shareholder, Jindadi Investment, has pledged 12.5 million shares, which represents 8.77% of its holdings and 2.55% of the company's total share capital, for debt repayment purposes [1] Group 1 - On November 27, Jindadi Investment notified the company about the pledge of 12.5 million shares, with a maturity date set for November 26, 2027 [1] - The pledged shares were released on November 28, with the same percentage representation as the pledge [1] - As of the announcement date, Jindadi Investment has cumulatively pledged 37.5 million shares, accounting for 26.32% of its holdings and 7.64% of the company's total share capital, with no risk of forced liquidation or transfer of ownership [1]